Monoclonal anti-FMC63 antibody, mouse IGG1 (Y45) (CARRIER-FREE) (recommended for ADA assay) DMF filed
Ended Purchase Order Awarded
- Contract number
- 75N90023P00450
- Awardee
-
Acrobiosystems Inc. UEI R1JEN78AMQD5
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,903
Award facts
- Contract value 100% obligated
- $12,903.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Newark, DE, USA
Award details come from SAM.gov/FPDS.
About this award
The NIH Clinical Center awarded a purchase order to Acrobiosystems Inc. on May 26, 2023, with a ceiling value of $12,903.00 on a firm fixed-price basis, under no set-aside. The order procures carrier-free monoclonal anti-FMC63 antibody, mouse IgG1 (Y45), recommended for ADA assay, with a DMF filed. Place of performance is Newark, DE. The ultimate completion date is July 31, 2023.
Quick answers
Who was awarded contract 75N90023P00450?
75N90023P00450 was awarded to Acrobiosystems Inc. by NIH Clinical Center (National Institutes of Health) on May 26, 2023.
How much is contract 75N90023P00450 worth?
The government has obligated $12,903 on 75N90023P00450.
Was contract 75N90023P00450 competed?
The extent of competition for 75N90023P00450 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award